The effects of co-dergocrine on cyclosporin A pharmacokinetics and pharmacodynamics. 1987

D A Heinrichs, and R Martell, and C R Stiller, and D Freeman, and G Carruthers

UI MeSH Term Description Entries
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D004088 Dihydroergotoxine A mixture of three different hydrogenated derivatives of ERGOTAMINE: DIHYDROERGOCORNINE; DIHYDROERGOCRISTINE; and DIHYDROERGOCRYPTINE. Dihydroergotoxine has been proposed to be a neuroprotective agent and a nootropic agent. The mechanism of its therapeutic actions is not clear, but it can act as an alpha-adrenergic antagonist and a dopamine agonist. The methanesulfonate salts of this mixture of alkaloids are called ERGOLOID MESYLATES. Co-Dergocrine,Ergot Alkaloids, Hydrogenated,Dihydroergotoxin,Alkaloids, Hydrogenated Ergot,Hydrogenated Ergot Alkaloids
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D A Heinrichs, and R Martell, and C R Stiller, and D Freeman, and G Carruthers
January 1992, Developmental pharmacology and therapeutics,
D A Heinrichs, and R Martell, and C R Stiller, and D Freeman, and G Carruthers
January 1999, European journal of clinical pharmacology,
D A Heinrichs, and R Martell, and C R Stiller, and D Freeman, and G Carruthers
December 1986, Lancet (London, England),
D A Heinrichs, and R Martell, and C R Stiller, and D Freeman, and G Carruthers
January 2001, Critical reviews in therapeutic drug carrier systems,
D A Heinrichs, and R Martell, and C R Stiller, and D Freeman, and G Carruthers
January 1992, European journal of drug metabolism and pharmacokinetics,
D A Heinrichs, and R Martell, and C R Stiller, and D Freeman, and G Carruthers
January 1990, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
D A Heinrichs, and R Martell, and C R Stiller, and D Freeman, and G Carruthers
January 1985, Journal de pharmacologie,
D A Heinrichs, and R Martell, and C R Stiller, and D Freeman, and G Carruthers
January 1985, Journal de pharmacologie,
D A Heinrichs, and R Martell, and C R Stiller, and D Freeman, and G Carruthers
August 2001, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
D A Heinrichs, and R Martell, and C R Stiller, and D Freeman, and G Carruthers
August 2015, Clinical pharmacokinetics,
Copied contents to your clipboard!